Access to Sterile Injecting Equipment is More Important Than Awareness of HCV Status for Injection Risk Behaviors Among Drug Users

References

• Alter M. J., Seeff L. B., Bacon B. R., Thomas D. L., Rigsby M. O., Di Bisceglie A. M. Testing for hepatitis C virus infection should be routine for persons at increased risk for infection. Annals of Internal Medicine 2004; 141: 715–717
   PubMed Web of Science ®Google Scholar
• Best D., Noble A., Finch E., Gossop M., Sidwell C., Strang J. Accuracy of perceptions of hepatitis B and C status: cross sectional investigation of opiate addicts in treatment. British Medical Journal 1999; 319: 290–291
   PubMed Web of Science ®Google Scholar
• Bowden S., McCaw R., White P. A., Crofts N., Aitken C. K. Detection of multiple hepatitis C virus genotypes in a cohort of injecting drug users. Journal of Viral Hepatitis 2005; 12: 322–324
   PubMed Web of Science ®Google Scholar
• Centers f or Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recommendations and Reports 1998; 47(RR-19)1–39
   PubMedGoogle Scholar
• Cox J., Stephenson R., Morissette C., Roy E., Graves L., Allard R., Mereb C. Development of a questionnaire on hepatitis C–related knowledge, attitudes and behaviors of injection drug users. Journal of Urban Health 2002; 79(4)S99
   Google Scholar
• Craine N., Walker M., Carnwath T., Klee H. Hepatitis C testing and injecting risk behaviour: the results of a UK based pilot study. International Journal of Drug Policy 2004; 15: 115–122
   Google Scholar
• Darke S. Self-report among injecting drug users: a review. Drug and Alcohol Dependence 1998; 51: 253–263
   PubMed Web of Science ®Google Scholar
• Davis M., Rhodes T., Martin A. Preventing hepatitis C: “common sense”, “the bug” and other perspectives from the risk narratives of people who inject drugs. Social Science and Medicine 2004; 59: 1807–1818
   PubMed Web of Science ®Google Scholar
• Direction de santé publique de Montréal. VIH/Hépatite C—Information aux professionnels. Appel à la vigilance—Août 2006: Recrudescence d'infections par le virus de l'immunodéficience humaine (VIH) et le virus de l'hépatite C (VHC) chez les utilisateurs de drogues injectables (UDI) de Montréal. 2006, Retrieved January 10, 2008, from http://www.santepub-mtl.qc.ca/Mi/vigilance/31082006.html
   Google Scholar
• Dowling-Guyer S., Johnson M. E., Fisher D. C., Needle R., Waltters J., Andersen M., Williams M., Kotranski L. Reliability of drug users' self-reported HIV risk behaviors and validity of self-reported drug use. Assessment 1994; 1: 383–392
   Google Scholar
• Graves L., Cox J., Lambert-Lanning A., Stephenson R., Steben M. Knowledge, perceptions and attitudes of Canadian family physicians about Hepatitis C. 2005, October, Poster session presented at the North American Primary Care Research Group Annual Meeting, Quebec City, Canada. Retrieved January 10, 2007, from http://www.fmdrl.org/index.cfm?event=c.AccessResourceandrid=213.
   Google Scholar
• Hagan H., Campbell J., Thiede H., Strathdee S., Ouellet L., Kapadia F., Hudson S., Garfein R. S. Self-reported hepatitis C virus antibody status and risk behavior in young injectors. Public Health Reports 2006; 121: 710–719
   PubMed Web of Science ®Google Scholar
• Hagan H., Jarlais D. C., Friedman S. R., Purchase D., Alter M. J. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. American Journal of Public Health 1995; 85: 1531–1537
   PubMed Web of Science ®Google Scholar
• Hagan H., Thiede H., Weiss N. S., Hopkins S. G., Cuchin J. S., Alexander E. R. Sharing of drug preparation equipment as a risk factor for hepatitis C. American Journal of Public Health 2001; 91: 42–46
   PubMed Web of Science ®Google Scholar
• Hahn J. A., Page-Shafer K., Lum P. J., Bourgois P., Stein E., Evans J. L., Busch M. P., Tobler L. H., Phelps B., Moss A. R. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. Journal of Infectious Diseases 2002; 186: 1558–1564
   PubMed Web of Science ®Google Scholar
• Hankins C., Alary M., Parent R., Blanchette C., Claessens C., the SurvUDI Working Group. Continuing HIV transmission among injection drug users in Eastern Central Canada: the SurvUDI Study, 1995 to 2000. Journal of Acquired Immune Deficiency Syndromes 2002; 30: 514–521
   PubMed Web of Science ®Google Scholar
• Hartel D. M., Schoenbaum E. E., Selwyn P. A., Friedland G. H., Klein R. S., Drucker E. Patterns of heroin, cocaine and speedball injection among Bronx (USA) methadone maintenance patients: 1978–1988. Addiction Research 1997; 8: 394–404
   Google Scholar
• Health Canada and The College of Family Physicians of Canada. Physicians' desk reference: primary care management of hepatitis C. 2002, Retrieved January 10, 2007, from http://www.cfpc.ca/English/cfpc/programs/patient%20care/hepatitis%20c/primary/default.asp?s=1.
   Google Scholar
• Heimer R., Clair S., Grau L. E., Bluthenthal R. N., Marshall P. A., Singer M. Hepatitis-associated knowledge is low and risks are high among HIV-aware injection drug users in three US cities. Addiction 2002; 97: 1277–1287
   PubMed Web of Science ®Google Scholar
• Herring B. L., Page-Shafer K., Tobler L. H., Delwart E. L. Frequent hepatitis C virus superinfection in injection drug users. Journal of Infectious Diseases 2004; 190: 1396–1403
   PubMed Web of Science ®Google Scholar
• Hosmer D. W., Jr., Lemeshow S. Applied logistic regression. John Wiley, New York 1989
   Google Scholar
• Joseph J. G., Emmons C. A., Kessler R. C., Wortman C. B., O'Brien K., Hocker W. T., Schaefer C. Coping with the threat of AIDS. An approach to psychosocial assessment. American Psychologist 1984; 39: 1297–1302
   PubMed Web of Science ®Google Scholar
• Koester S., Booth R. E., Zhang Y. The prevalence of additional injection-related HIV risk behaviors among injection drug users. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1996; 12: 202–207
   PubMedGoogle Scholar
• Kwiatkowski C. F., Fortuin Corsi K., Booth R. E. The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users. Addiction 2002; 97: 1289–1294
   PubMed Web of Science ®Google Scholar
• Latkin C. A., Forman V., Knowlton A., Sherman S. Norms, social networks, and HIV-related risk behaviors among urban disadvantaged drug users. Social Science and Medicine 2003; 56: 465–476
   PubMed Web of Science ®Google Scholar
• Leclerc P., Morissette C. Situation épidémiologique des infections transmissibles sexuellement et par le sang (ITSS) pour la région de Montréal. Pascale Leclerc, Carole Morissette. Direction de santé publique de Montréal. 2006a, Retrieved January 10, 2007, from http://www.santepub-mtl.qc.ca/Publication/mts/itsssituation.html
   Google Scholar
• Leclerc P., Morissette C., Roy É., Tremblay C., Alary M. Accès au matériel stérile d'injection et aux soins médicaux pour les utilisateurs de drogues par injection de Montréal. 2006b, October, Poster session presented at the Les journées annuelles de santé publique, Montreal, Quebec, Canada
   Google Scholar
• Loxley W., Bolleter A., Carruthers S. Talking about testing: opportunities for prevention in blood borne virus testing and vaccination with injectors. National Drug Research Institute, Perth, Australia 2001
   Google Scholar
• Morissette C., Cox J., De P., Tremblay C., Roy E., Allard R., Stephenson R., Graves L. Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: implications for HIV and hepatitis C prevention. International Journal of Drug Policy 2007; 18: 204–212
   PubMed Web of Science ®Google Scholar
• Needle R. H., Coyle S., Cesari H., Trotter R., Clatts M., Koester S., Price L., McLellan E., Finlinson A., Bluthenthal R. N., Pierce T., Johnson J., Jones T. S., Williams M. HIV risk behaviors associated with the injection process: multiperson use of drug injection equipment and paraphernalia in injection drug user networks. Substance Use and Misuse 1998; 33: 2403–2423
   PubMed Web of Science ®Google Scholar
• National Institutes of Health Expert Panel. NIH consensus statement on management of hepatitis C: 2002. NIH Consensus State Science Statements 19:1–46. 2002, Retrieved August 20, 2006, from http://consensus.nih.gov/2002/2002HepatitisC2002116PDF.pdf.
   Google Scholar
• Ompad D. C., Fuller C. M., Vlahov D., Thomas D., Strathdee S. A. Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland. Clinical Infectious Diseases 2002; 35: 783–788
   PubMed Web of Science ®Google Scholar
• Prochaska J. O., DiClemente C. C., Norcross J. C. In search of how people change: applications to addictive behaviors. American Psychologist 1992; 47: 1102–1114
   PubMed Web of Science ®Google Scholar
• Remis R. S., Bruneau J., Hankins C. A. Enough sterile syringes to prevent HIV transmission among injection drug users in Montreal?. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1998; 18(Suppl. 1)S57–S59
   Google Scholar
• Rhodes T., Davis M., Judd A. Hepatitis C and its risk management among drug injectors in London: renewing harm reduction in the context of uncertainty. Addiction 2004; 99: 621–633
   PubMed Web of Science ®Google Scholar
• Roy É., Alary M., Morissette C., Leclerc P., Boudreau J-F., Parent R., Rochefort J., Claessens C., the SurvUDI Working Group. High hepatitis C virus prevalence and incidence among Canadian intravenous drug users. International Journal of STD and AIDS 2007; 18: 23–27
   PubMed Web of Science ®Google Scholar
• Shehab T. M., Sonnad S. S., Jeffries M., Gunaratnum N., Lok A. S. Current practice patterns of primary care physicians in the management of patients with hepatitis C. Hepatology 1999; 30: 794–800
   PubMed Web of Science ®Google Scholar
• Sherman M., Bain V., Villeneuve J. P., Myers R. P., Cooper C., Martin S., Lowe C. The management of chronic viral hepatitis: A Canadian consensus conference 2004. Canadian Journal of Infectious Diseases & Medical Microbiology 2004; 15: 313–326
   PubMedGoogle Scholar
• Stein M. D., Maksad J., Clarke J. Hepatitis C disease among injection drug users: knowledge, perceived risk and willingness to receive treatment. Drug and Alcohol Dependence 2001; 61: 211–215
   PubMed Web of Science ®Google Scholar
• Thorpe L., Ouellet L. J., Hershow R., Bailey S. L., Williams I. T., Williamson J., Monterroso E. R., Garfein R. S. Risk of hepatitis C virus injection among young adult injection drug users who share injection equipment. American Journal of Epidemiology 2002; 155: 645–653
   PubMed Web of Science ®Google Scholar
• US Preventive Services Task Force. Screening for hepatitis C virus infection in adults: recommendation statement. Annals of Internal Medicine 2004; 140: 462–464
   PubMed Web of Science ®Google Scholar
• Vidal-Trécan G., Coste J., Varescon-Pousson I., Christoforov B., Boissonnas A. HCV status knowledge and risk behaviours amongst intravenous drug users. . European Journal of Epidemiology 2000; 16: 439–445
   PubMed Web of Science ®Google Scholar
• Zimmerman G. L., Olsen C. G., Bosworth M. F. A “stages of change” approach to helping patients change behavior. American Family Physician 2000; 61: 1409–1416
   PubMed Web of Science ®Google Scholar